Posted on September 14, 2020September 17, 2020 by Sierra BergsgaardVIC Fellow Spotlight: Dr. Greg Tucker The VIC Fellows Program was created in late 2019 as a mechanism for individuals with specific expertise to learn about and be involved in identifying and evaluating promising life science innovations from universities. > Read More
Posted on September 11, 2020September 17, 2020 by Sierra BergsgaardPartner Spotlight: OmniValley VIC is pleased to work with OmniValley in supporting their mission to better connect fund and startup company investors to one another. OmniValley is an exclusive, online investor network built to offer connections. > Read More
Posted on September 2, 2020September 17, 2020 by Sierra BergsgaardThe Anatomy of a Friends and Family Round in a COVID-19 World When I wrote about fundraising early this year, I knew that I would be raising a round shortly, but had no idea I would be doing it in a changed COVID-19 world. > Read More
Posted on August 17, 2020September 17, 2020 by Sierra BergsgaardOpportunity Assessment: How To Vet So Much Tech How do you successfully evaluate hundreds of complicated technologies each year, with a team spread across the country and resources that span the globe? This was the challenge that VIC needed to solve. > Read More
Posted on August 10, 2020September 17, 2020 by Sierra BergsgaardSolenic Medical Receives FDA Breakthrough Device Designation TEXAS – July 29, 2020 – Solenic Medical, a developer of a device that uses alternating magnetic fields to treat a prosthetic joint infections (PJI) announced today that it has received Breakthrough Device designation. > Read More
Posted on July 14, 2020August 10, 2020 by Sierra BergsgaardVIC 2020 Mid-Year Update So far, in 2020, VIC’s portfolio of companies reached numerous milestones and potential business partners are increasingly finding ways to re-engage in spite of the ongoing pandemic. The VIC Foundry has expanded considerably and the VIC Fellows program launched. > Read More
Posted on July 13, 2020August 10, 2020 by Sierra BergsgaardVixiar: Solving a Big Problem With a Small Device Last month at Vixiar Medical, we reached a major milestone on the road to commercial launch of our Indicor™ device with the submission of our 510(k) to the FDA. We hope to have clearance to market our product in the fall, after which we will begin our first phase of commercial activity. > Read more
Posted on July 7, 2020August 10, 2020 by Sierra BergsgaardPortfolio Diversification in Times of Market Volatility As of writing this article, it’s mid-July 2020, and the uncertainty around the long-term impact of the COVID-19 pandemic continues to grow. As with any new virus, its behavior is unpredictable, and this is even more the case given its genetic material is RNA, which is highly prone to evolving and adapting through mutation. > Read more
Posted on June 22, 2020June 26, 2020 by Sierra BergsgaardThe Emerging Remote Workplace: Digital Best Practices for Investor Groups As the recent pandemic has made all too clear, organizations need to proactively prepare for the realities of a dispersed workforce, which is especially true for investor groups such as venture capital and private equity. > Read more
Posted on June 18, 2020June 26, 2020 by Sierra BergsgaardNeurexis Therapeutics Awarded Colorado Advanced Industries Accelerator Grant AURORA, CO – Neurexis Therapeutics, Inc. announced today that it has been approved for funding as part of the Colorado Office of Economic Development and International Trade’s (OEDIT) Advanced Industries Accelerator Program. > Read more
